New Zealand reports first Covid vaccine death: Woman dies after Pfizer jab
August 30, 2021 at 04:51 am EDT
Share
A health board that monitors vaccine safety said today that a woman had died from myocarditis after being given the Pfizer jab. The case marks New Zealand’s first reported coronavirus vaccine death.
The board said the woman probably developed the condition because of the vaccine, although she had other medical issues which may have contributed.
Director-general of health Ashley Bloomfield said myocarditis is a very rare side-effect and there is clear evidence that having a vaccination is much safer than being infected with Covid-19.
Health authorities have so far administered vaccines to more than two million New Zealanders.
The board declined to answer questions from the Associated Press, including the woman’s age and the date of her death, citing protocol because a coroner is investigating the case further.
Meanwhile, New Zealand Prime Minister Jacinda Ardern said Auckland will remain in strict lockdown for at least two more weeks and the rest of the country for at least another week, but with slightly fewer restrictions, as the nation battles an outbreak of the Delta variant, which was first identified in India.
The post New Zealand reports first Covid vaccine death: Woman dies after Pfizer jab appeared first on CityAM.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).